Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025Blood

Implementation of an innovative hospital at home program for patients with hematalogic malignancies

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPeter C. ChangMMMegan MelodyDSDavid M. Swoboda

Discussion

Loading...

Member takes

Overview

Implementation of a novel home care program improved outcomes for patients with hematologic malignancies, suggesting benefits over traditional inpatient care.

Key Points

  • To evaluate the effectiveness of a Hospital at Home program for patients with hematologic malignancies during induction chemotherapy.
  • Implemented a home care program at a tertiary cancer institute for hematologic patients.
  • Patients monitored using continuous telemetry via Biobeat biometric patch and received in-home services.
  • Eligible patients had to meet specific criteria, including absence of fever for 48 hours and availability of a caregiver.
  • 36 of 77 screened patients (46.8%) successfully transitioned to Hospital at Home.
  • Patients saved 183 inpatient bed-days with a median of 5 days per patient enrolled.
  • No 30-day mortality reported and lower readmission rates than traditional early discharge programs.

Cite This Study

Chang et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d1dfhttps://doi.org/10.1182/blood-2025-520
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hospital-at-home for acute complicated diverticulitis: a single-arm feasibility study2025
  2. 2Impact of hospital admissions through the emergency department versus direct admissions for patients with hematologic malignancies: A single site analysis2025
  3. 3Hospital at Home in Calgary, Canada: An opportunity for real-world care planning and integration.2025
  4. 4Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy2025
  5. 5Safety and implementation of a regional hospital-at-home model: a retrospective observational study from Denmark2026